• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of superoxide in pulmonary hypertension and treatment with xanthine oxidase inhibition

Research Project

Project/Area Number 26462357
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Anesthesiology
Research InstitutionMie University

Principal Investigator

Yokochi Ayumu  三重大学, 医学部附属病院, 講師 (60359768)

Co-Investigator(Kenkyū-buntansha) 丸山 一男  三重大学, 医学系研究科, 教授 (20181828)
澤田 博文  三重大学, 医学系研究科, 講師 (30362354)
張 尓泉  三重大学, 医学系研究科, 助教 (30456727)
Research Collaborator MARUYAMA Junko  
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords肺高血圧 / スーパーオキシド / キサンチンオキシダーゼ / フェブキソスタット / Febuxostat / 一酸化窒素 / モノクロタリン / 低酸素 / uncoupled NOS / 肺高血圧症
Outline of Final Research Achievements

Febuxostat, being a novel xanthine oxidase inhibitor, is apparently having a beneficial role in improving the endothelial dysfunction. The purpose of the present study was to investigate whether febuxostat (FBS) prevents the development of pulmonary hypertension (PH) in both monocrotaline (MCT)-injected rats and in rats exposed to chronic hypobaric hypoxia (CH)(380 mm Hg, 10% oxygen).
The mean pulmonary artery pressure (mPAP), right ventricular hypertrophy (RVH), percentages of muscularized peripheral arteries (%muscularization), and medial wall thickness of small muscular arteries (%MWT) were measured. MCT increased mPAP, RVH, %muscularization, and %MWT.CH increased mPAP, RVH, %muscularization, and %MWT.FBS treatment did not significantly reduced mPAP, RVH, %muscularization, and %MWT in both MCT-injected rats and in rats exposed to CH. FBS does not appear to prevent the development of pulmonary hypertension (PH) in both MCT-injected rats and in rats exposed to CH.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi